These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25828954)

  • 1. Polyclonality of Parathyroid Tumors in Neonatal Severe Hyperparathyroidism.
    Corrado KR; Andrade SC; Bellizzi J; D'Souza-Li L; Arnold A
    J Bone Miner Res; 2015 Oct; 30(10):1797-802. PubMed ID: 25828954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder.
    Diaz-Thomas A; Cannon J; Iyer P; Al-Maawali A; Fazalullah M; Diamond F; Mueller OT; Root AW; Alyaarubi S
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):851-6. PubMed ID: 24854525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene.
    Marx SJ; Sinaii N
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1061-78. PubMed ID: 31778168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation.
    Wejaphikul K; Dejkhamron P; Khorana J; Watcharachan K; Intachai W; Olsen B; Tongsima S; Ketudat Cairns JR; Ngamphiw C; Kantaputra P
    Horm Res Paediatr; 2023; 96(4):432-438. PubMed ID: 36626889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation.
    Gulcan-Kersin S; Kirkgoz T; Eltan M; Rzayev T; Ata P; Bilgen H; Ozek E; Bereket A; Turan S
    Horm Res Paediatr; 2020; 93(5):313-321. PubMed ID: 33147586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic defects associated with familial and sporadic hyperparathyroidism.
    Hendy GN; Cole DE
    Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathophysiology of primary hyperparathyroidism.
    Brown EM
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N24-9. PubMed ID: 12412774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel homozygous inactivating mutation of the calcium-sensing receptor gene in neonatal severe hyperparathyroidism responding to cinacalcet therapy: A case report and literature review.
    Sun X; Huang L; Wu J; Tao Y; Yang F
    Medicine (Baltimore); 2018 Nov; 97(45):e13128. PubMed ID: 30407334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.
    Frank-Raue K; Leidig-Bruckner G; Haag C; Schulze E; Lorenz A; Schmitz-Winnenthal H; Raue F
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):50-5. PubMed ID: 21521328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel homozygous inactivating mutation of the calcium-sensing receptor gene (CASR) in neonatal severe hyperparathyroidism-lack of effect of cinacalcet.
    Atay Z; Bereket A; Haliloglu B; Abali S; Ozdogan T; Altuncu E; Canaff L; Vilaça T; Wong BY; Cole DE; Hendy GN; Turan S
    Bone; 2014 Jul; 64():102-7. PubMed ID: 24735972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism.
    Kobayashi M; Tanaka H; Tsuzuki K; Tsuyuki M; Igaki H; Ichinose Y; Aya K; Nishioka N; Seino Y
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2716-9. PubMed ID: 9253359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
    Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
    Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation.
    Capozza M; Chinellato I; Guarnieri V; Di Lorgi N; Accadia M; Traggiai C; Mattioli G; Di Mauro A; Laforgia N
    BMC Pediatr; 2018 Oct; 18(1):340. PubMed ID: 30376845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene.
    Tõke J; Czirják G; Patócs A; Enyedi B; Gergics P; Csákváry V; Enyedi P; Tóth M
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):385-92. PubMed ID: 17555508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review.
    Gannon AW; Monk HM; Levine MA
    J Clin Endocrinol Metab; 2014 Jan; 99(1):7-11. PubMed ID: 24203066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an induced pluripotent stem cell line HPCASRi002-A from a patient with neonatal severe primary hyperparathyroidism caused by a compound heterozygous mutation in the CASR gene.
    Panova AV; Kulikova KS; Klementieva NV; Krylov ID; Snezhko IO; Tiulpakov AN; Kiselev SL
    Stem Cell Res; 2021 Jul; 54():102414. PubMed ID: 34111698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism.
    Dwight T; Nelson AE; Theodosopoulos G; Richardson AL; Learoyd DL; Philips J; Delbridge L; Zedenius J; Teh BT; Larsson C; Marsh DJ; Robinson BG
    Am J Pathol; 2002 Oct; 161(4):1299-306. PubMed ID: 12368203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in the calcium sensing receptor gene in a neonate with severe hyperparathyroidism.
    Kahvecioglu D; Atasay B; Berberoglu M; Yildiz D; Cakir U; Akduman H; Erdeve O; Siklar Z; Magdelaine C; Lienhardt-Roussie A; Akar M; Ozbek MN; Arsan S
    Genet Couns; 2014; 25(3):331-5. PubMed ID: 25365856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.